No results found for "".

Commentary & Deal Flow

Related Parents

Related Issuers

ALLOCATIONS OUT: Sanofi €2.3bn 3yr, 7yr & 11yr Sr Unsec; MS+28, MS+50 & MS+70

IGC European Market: Deal Flow - General

Issuer

Term

Maturity

Size

Ranking

Type

IPT

Guidance

Spread Set

ISIN

Sanofi

3yr

05-May-29

€1bn

Sr Unsec

Fixed

MS+60a

MS+28

MS+28

FR0014016SU0

Sanofi

7yr

05-May-33

€650m

Sr Unsec

Fixed

MS+80/85

MS+50

MS+50

FR0014016SW6

Sanofi

11yr

05-May-37

€650m

Sr Unsec

Fixed

MS+100a

MS+70

MS+70

FR0014016SX4


Tranche 1 (3yr): Final Books €2.1bn+. Peak book €2.4bn+.
Tranche 2 (7yr): Final Books €1.4bn+. Peak book €1.6bn+.
Tranche 3 (11yr): Final Books €1.7bn+. Peak book €1.8bn+.


Launched:
3yr: €1bn @ MS+28bp - Books €2.4bn+
7yr: €650m @ MS+50bp - Books €1.6bn+
11yr: €650m @ MS+70bp - Books €1.8bn+
Guidance:
3yr: MS+28bp - Books €3.1bn+
7yr: MS+50bp - Books €2.0bn+
11yr: MS+70bp - Books €2.0bn+
IPTs: 3yr: MS+60bp area 7yr: MS+80-85bp 11yr: MS+100bp area


  • Issuer: Sanofi
  • Ticker: SANFP
  • Country: FR
  • Issuer LEI: 549300E9PC51EN656011
  • Issuer Ratings: Aa3/AA/AA (Moody's/S&P/Scope)
  • Issue Expected Ratings: Aa3/AA/AA (Moody's/S&P/Scope)
  • Format of Notes: Senior Unsecured, Unsubordinated Reg S (Cat 2) Bearer dematerialized
  • Pricing Date: 24-Apr-26
  • Settlement Date: 05-May-26 (T+6)
  • Issue Size:
    • 3-year: €1bn
    • 7-year: €650m
    • 11-year: €650m
  • Total Size: €2.3bn
  • Maturity Date:
    • 3-year: 05-May-29
    • 7-year: 05-May-33
    • 11-year: 05-May-37
  • Coupon:
    • 3-year: [●] % Fixed, Annual, ACT/ACT (ICMA)
    • 7-year: [●] % Fixed, Annual, ACT/ACT (ICMA)
    • 11-year: [●] % Fixed, Annual, ACT/ACT (ICMA)
  • Par Call:
    • 3-year: 1-month
    • 7-year: 3-month
    • 11-year: 3-month
  • Clean-up Call:
    • 3-year: 75%
    • 7-year: 75%
    • 11-year: 75%
  • Make-Whole Call:
    • 3-year: [●]
    • 7-year: [●]
    • 11-year: [●]
  • Benchmark:
    • 3yr: OBL 2.1% Apr-29s / HR 101%
    • 7yr: DBR 2.3% Feb-33s / HR 102%
    • 11yr: DBR 4.0% Jan-37s / HR 94%
  • Denominations: €100k+€100k
  • Use of Proceeds: General Financing and Corporate Purposes
  • ISIN:
    • 3-year: FR0014016SU0
    • 7-year: FR0014016SW6
    • 11-year: FR0014016SX4
  • Listing and Documentation: Euronext Paris (Regulated Market) / EMTN Programme Base Prospectus dated 4 June 2025 as supplemented on 13 June 2025, 27 February 2026 and 23 April 2026
  • Clearing: Euroclear France
  • Governing Law: French Law
  • Global Coordinators: Citi, HSBC and J.P. Morgan (B&D)
  • Active Bookrunners: CACIB, Citi, Deutsche Bank, HSBC, J.P. Morgan (B&D), RBC Capital Markets and UniCredit
  • Billing & Delivery: J.P. Morgan
  • Hedge Deadline: 15.45 UKT / 16.45 CET
  • Target Market: The manufacturer target market (MIFID II/UK MIFIR product governance) is eligible counterparties and professional clients (all distribution channels). No EEA PRIIPs key information document (KID) or UK PRIIPs KID/CCI product summary has been prepared as not available to retail in the EEA or the United Kingdom.
  • Advertisement Language: The Base Prospectus and any supplement are available on the AMF's and the Issuer’s website - The Final Terms when published will be available on the AMF's website (https://www.amf-france.org) - The documents will also be available on the issuer’s website (www.sanofi.com).
  • Timing: Books Open, Today’s Business
  • Books Subject: Books to go subject at 12.40 UKT / 13.40 CET